Recombinant
RabMAb

Recombinant Anti-eIF4E (phospho S209) antibody [EP2151Y] - BSA and Azide free (ab183301)

Publishing research using ab183301? Please let us know so that we can cite the reference in this datasheet.

ab183301 has been referenced in 6 publications.

  • Chung CH  et al. Butein Inhibits Angiogenesis of Human Endothelial Progenitor Cells via the Translation Dependent Signaling Pathway. Evid Based Complement Alternat Med 2013:943187 (2013). WB ; Rat . PubMed: 23840271
  • Martineau Y  et al. Pancreatic tumours escape from translational control through 4E-BP1 loss. Oncogene N/A:N/A (2013). PubMed: 23563181
  • Wang XQ  et al. The differential proliferative ability of satellite cells in Lantang and Landrace pigs. PLoS One 7:e32537 (2012). WB ; Pig . PubMed: 22427853
  • Liu T  et al. Combinatorial effects of lapatinib and rapamycin in triple-negative breast cancer cells. Mol Cancer Ther 10:1460-9 (2011). WB ; Human . PubMed: 21690228
  • Mockett BG  et al. Calcium/Calmodulin-Dependent Protein Kinase II Mediates Group I Metabotropic Glutamate Receptor-Dependent Protein Synthesis and Long-Term Depression in Rat Hippocampus. J Neurosci 31:7380-91 (2011). WB ; Rat . PubMed: 21593322
  • Fan S  et al. Phosphorylated eukaryotic translation initiation factor 4 (eIF4E) is elevated in human cancer tissues. Cancer Biol Ther 8:1463-9 (2009). IHC-P ; Human . PubMed: 19483468

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up